Every biopharma company is eventually faced with the “make versus buy” decision – should they do the fill/finish manufacturing of their drug product in-house or outsource? Complicating things further, a
Questions asked when planning Life Science Manufacturing Automation and Scale-up In life science manufacturing automation and scale-up is challenging. When picturing a manufacturing line, you likely conjure up images of
Life Science Cold Chain Logistics Life science companies, from reagents to diagnostics, rely on cold chain shipping. A vital component in the chain is the ubiquitous polystyrene cooler. Yet, with
Strategic plays to grow your biotech startup Being a biotech startup is exciting. Your company is young, energetic, and full of potential. However, your company is likely lacking in two
Blockbuster drugs and one-size-fits-all treatments now share portfolio space with highly targeted therapies for smaller patient populations. This new era is an opportunity for savvy companies to create greater value,
Preparing now for the switch to ISO 13485:2016 For decades, there has been a divide in the medical device regulatory landscape. While the U.S. Food and Drug Administration (FDA) has
The BIO International 2019 conference is only one week away! Here at Argonaut, our team is preparing for a week filled with partnership meetings and exciting talks. This year a
Outsourcing pharmaceutical manufacturing is becoming essential to remain competitive in the industry. The rise of small-batch personalized medicines and “virtual companies” are key drivers to retain flexible, external manufacturing capabilities. With various
Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials, along with the evaluation of potential applications in clinical diagnostics and
ISPE Aseptice Conference – “Facility of the Future” The always-essential 2019 ISPE Aseptic Conference was held in North Bethesda, MD and we were there to assess the trends, check out